Materialise’s 3D Printed Tracheobronchial Splint Set for New FDA Trials
Belgian 3D printing software company Materialise is leading a new US Food and Drug Administration (FDA) clinical trial for a bioresorbable, 3D printed tracheobronchial splint. Developed in collaboration with the University of Michigan (U-M)’s Michigan Medicine and U-M Health, the device treats children with collapsed trachea and bronchial tubes. This condition, known as tracheobronchomalacia, affects […]
